We are delighted to share that BioEclosion was featured on Cadena SER in Los Revolucionarios, as part of La Ventana with Carles Francino. In this interview, Jofre Ferrer-Dalmau, CEO and co-founder of BioEclosion, explains how our technology is helping transform rapid diagnostics by bringing testing closer to people, without the need to go to a …
by Isabel Pividori 
Showcasing its technology at the UAB stand and selected to pitch at the BKA Pitch Corner, Bioeclosion presented its portable diagnostic device to investors, partners, and innovation stakeholders at Europe’s leading startup event. Barcelona, March 2026 — Bioeclosion participated in 4YFN-MWC 2026, the startup event held within the Mobile World Congress programme in Barcelona, where the company …
by Isabel Pividori 
BioEclosion will be at Mobile World Congress 2026 (2–5 March, Barcelona) within the UAB stand (8.1C43), exhibiting next-generation biosensor technology for advanced diagnostic devices. BioEclosion will also pitch at the BKA Pitch Corner on 3 March, connecting with investors and partners across the deep-tech ecosystem. BioEclosion will be at Mobile World Congress (MWC) 2026 in …
by Isabel Pividori 
A rapid diagnostic technology developed by BioEclosion and the Universitat Autònoma de Barcelona (UAB) has been assessed by the European Commission’s Innovation Radar and classified as “Market Ready”, with “Market Creation Potential: Noteworthy”. The European Commission, through its Innovation Radar initiative, has evaluated and selected an innovation developed within the EU-funded EChiLiBRiST project. The innovation …
by Isabel Pividori 
A recent study demonstrates a point-of-care electrochemical biosensing workflow to quantify an Alzheimer’s-relevant marker on neuron-origin exosomes isolated from plasma. The assay is implemented in a disposable, magneto-actuated cartridge and the electrochemical signal is acquired using BioEclosion’s portable device. Early diagnosis of Alzheimer’s disease remains one of the major challenges in healthcare, largely because many …
by Isabel Pividori 
Transforming Breast Cancer Diagnosis. BioEclosion’s breakthrough in biosensing technology In an exciting development for the field of medical diagnostics, our latest product, the specialized cartridge for biosensing applications, has been featured in a pioneering study published in Biosensors and Bioelectronics. This study, titled “Peptide-based biosensing approaches for targeting breast cancer-derived exosomes”, marks a significant milestone in …
by Isabel Pividori 
Dr. Jofre Ferrer-Dalmau, CEO of BioEclosion, has recently participated in the last edition of BioSpain Congress, organized in Barcelona, 26-28th of September 2023.
by systems_gfpjfose Input your search keywords and press Enter.